Shinya Yamanaka delivering #ISID2023Tokyo lecture: OSKM factor expression restores DNA methylome of iPSC cells to “reset” DNA methylation age. Fascinating potential for rejuvination and regenerative medicine using HLA homozygous & HLA-C only iPSCs.

Thankful for ACIR featuring our recent work regarding anti-tumor memory. Great summary and visual infographic.

Today is a big day for #melanoma research and patient care with the U.S. FDA approval of the first T cell-based therapy for melanoma. Exciting possibilities ahead for "boosting" T cell effectiveness and developing the next generation of immunotherapies #dermtwitter

Tune in for the latest on acral melanoma 🔬

Thank you to Nature Cancer for featuring our journey Yale Cancer Center

May is #MelanomaAwarenessMonth. We are sharing our new review on DNA methylation in melanoma immunotherapy and resistance exploring how to improve immune responses and therapies for patients. #Epigenetics #CancerResearch Melanoma Research #dermtwitter

I am a physician scientist Yale Cancer Center taking care of patients with #cancer and direct a #melanoma research lab. On September 6, 2025, I am taking the fight against cancer to the streets (on a bicycle).  You can join my fundraising effort here: rideclosertofree.org/participants/3… Thank you!